Viva Biotech Holdings
Company Profile
Business description
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
Contact
735 Ziping Road
Pudong New District
Zhoupu Town
Shanghai201318
CHNT: +86 2160893288
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
2,063
Stocks News & Analysis
stocks
Our top ASX picks in every sector
stocks
Potentially catastrophic ruling for ASX company
stocks
4 charts on Nvidia’s record $4 trillion market cap
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,875.30 | 60.00 | 0.68% |
CAC 40 | 7,820.88 | 12.71 | 0.16% |
DAX 40 | 24,204.94 | 44.30 | 0.18% |
Dow JONES (US) | 44,459.65 | 88.14 | 0.20% |
FTSE 100 | 8,997.70 | 0.36 | -0.00% |
HKSE | 24,590.12 | 386.80 | 1.60% |
NASDAQ | 20,640.33 | 54.80 | 0.27% |
Nikkei 225 | 39,678.02 | 218.40 | 0.55% |
NZX 50 Index | 12,689.63 | 10.94 | 0.09% |
S&P 500 | 6,268.56 | 8.81 | 0.14% |
S&P/ASX 200 | 8,630.30 | 59.90 | 0.70% |
SSE Composite Index | 3,505.00 | 14.65 | -0.42% |